Darwin - Public Comps and Valuation Multiples

Darwin Overview

About Darwin

Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.

Founded

2021

HQ

Employees

n/a

Website

darwin-biotech.com

Sectors

Nutraceuticals & Cosmeceuticals
Health & Beauty
BioTech

Financials

Last FY Revenue $29.3M

Last FY EBITDA $42.6M

EV

-$64.4M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Darwin Financials

See Darwin valuation multiples based on analyst estimates

Darwin P&L

In the most recent fiscal year, Darwin reported revenue of $29.3M and EBITDA of $42.6M.

Darwin expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Darwin valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$29.3M	XXX	XXX	XXX
Gross Profit	XXX	$14.3M	XXX	XXX	XXX
Gross Margin	XXX	49%	XXX	XXX	XXX
EBITDA	XXX	$42.6M	XXX	XXX	XXX
EBITDA Margin	XXX	146%	XXX	XXX	XXX
EBIT	XXX	$30.5M	XXX	XXX	XXX
EBIT Margin	XXX	104%	XXX	XXX	XXX
Net Profit	XXX	$21.3M	XXX	XXX	XXX
Net Margin	XXX	73%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Darwin including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Darwin achieved $29.3M in revenue and $42.6M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$29.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$14.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	49.0% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$42.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	145.6% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$30.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	104.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$21.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	73.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Darwin

This financial data table provides comprehensive performance metrics for Darwin, a company based in Germany. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Darwin reported $29.3M in total revenue.
Fiscal year EBITDA was $42.6M.
The company maintained a gross profit margin of 49.0% in the most recent fiscal year.
EBITDA margin for the fiscal year was 145.6%.
Net profit margin reached 73.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Darwin. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Darwin Stock Performance

Darwin has current market cap of EUR 19.6M (or $22.7M), and EV of -EUR 55.7M (or -$64.4M).

Market Cap Evolution

Darwin Stock Data

As of October 17, 2025, Darwin's stock price is EUR 7 (or $8).

See Darwin trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
-$64.4M	$22.7M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Darwin Valuation Multiples

Darwin's trades at -2.2x EV/Revenue multiple, and -1.5x EV/EBITDA.

See valuation multiples for Darwin and 15K+ public comps

Darwin Financial Valuation Multiples

As of October 17, 2025, Darwin has market cap of $22.7M and EV of -$64.4M.

Equity research analysts estimate Darwin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Darwin's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$22.7M	XXX	$22.7M	XXX	XXX	XXX
EV (current)	-$64.4M	XXX	-$64.4M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	-2.2x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-1.5x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-2.1x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	1.1x	XXX	XXX	XXX
EV/FCF	n/a	XXX	1.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Darwin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Darwin Margins & Growth Rates

Darwin's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Darwin's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Darwin's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Darwin and other 15K+ public comps

Darwin Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	146%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	-55%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial